DANIELLE VANSTRIEN: Open Payments
NPI 1679901540 · TOPSHAM, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 11 payments from 8 companies in 2025. Trend: 2023 $284 · 2024 $244 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $27 |
| Astellas Pharma Global Development | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
Products named: EPKINLY, TAGRISSO, Enhertu, ZENPEP, ZYNLONTA, Vyloy, ELREXFIO, PYLARIFY.
Industry payments across ME — which companies pay providers there.
